UTI - Healthcare Fund

Regular Plan · Growth · Sectoral / Thematic · Scheme code 100807

NAV₹323.3297as on 27 Oct 2026

Fund houseUTI Mutual Fund

CategorySectoral / Thematic

Plan & optionRegular · Growth

History20.4 years

Returns (%)

	1M	3M	6M	1Y	3Y	5Y	7Y	10Y	Launch
This scheme	2.30	11.64	20.42	18.54	23.75	15.56	23.88	13.96	13.86
Nifty 500 benchmark	0.87	4.31	2.15	5.20	12.49	11.41	—	—	15.49
Sectoral / Thematic category median	—	—	—	-6.58	11.54	8.85	—	12.68	—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

	Volatility	Sharpe	Sortino	Beta	Alpha	Max fall	R²
This scheme	15.9%	1.08	1.92	0.77	12.79%	-33.9%	54.28
Nifty 500 benchmark	15.2%	0.39	0.58	—	—	-37.3%	—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 36 months this scheme and its benchmark share.

Growth of ₹100 since launch

Drawdown from peak (%)

Every one-year period it has lived through

Windows	Worst	Median	Best	Periods that lost money
4,774	-26.8%	12.1%	99.8%	31%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up capture	Down capture	Correlation	Tracking error	Information ratio	Treynor
116%	60%	0.74	11.3%	1.01	22.50

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 36 months this scheme and Nifty 500 share.

UTI - Healthcare Fund

Regular Plan · Growth

Allocation

By asset

Equity	94.15%
Cash & Equivalents	5.87%

By market cap

Large Cap	19.19%
Mid Cap	33.33%
Small Cap	38.43%
Unclassified	3.29%

Concentration

Number of stocks	44
Top 5 stocks	27.88%
Top 10 stocks	43.48%
Top 20 stocks	66.59%
Lines in the filing	46

Largest holding	7.62%
Largest sector	Pharmaceuticals & Biotechnology 68.48%
Effective stocks	33.0
Sectors held	4
Cash	5.87%

Effective stocks is what the concentration works out to: a fund holding 44 names but most of its money in a few behaves like a fund of 33. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology	68.48%
Healthcare Services	23.31%
Cash & Equivalents	5.87%
Chemicals & Petrochemicals	1.28%
Healthcare Equipment & Supplies	1.08%

UTI - Healthcare Fund

Regular Plan · Growth · holdings

Top 30 holdings

#	Company	Sector	Shares held	Value ₹ cr	% of fund
1	EQ - SUN PHARMACEUTICALS INDUSTRIES	Pharmaceuticals & Biotechnology	600,000	—	7.62%
2	EQ - DIVIS LABORATORIES LTD.	Pharmaceuticals & Biotechnology	94,707	—	6.15%
3	NET CURRENT ASSETS	Unclassified	—	—	5.85%
4	EQ - DR REDDYS LABORATORIES LTD.	Pharmaceuticals & Biotechnology	607,098	—	5.24%
5	EQ - AJANTA PHARMA LTD.	Pharmaceuticals & Biotechnology	190,000	—	4.81%
6	EQ - GLAND PHARMA LTD.	Pharmaceuticals & Biotechnology	200,000	—	4.06%
7	EQ - ALKEM LABORATORIES LTD	Pharmaceuticals & Biotechnology	102,500	—	3.70%
8	EQ - APOLLO HOSPITALS ENTERPRISE LT	Healthcare Services	53,000	—	3.03%
9	EQ - CAPLIN POINT LABORATORIES LTD	Pharmaceuticals & Biotechnology	159,030	—	3.02%
10	EQ- GLOBAL HEALTH LTD.	Healthcare Services	310,000	—	2.96%
11	EQ - LUPIN LTD.	Pharmaceuticals & Biotechnology	203,834	—	2.89%
12	EQ - IPCA LABORATORIES LTD.	Pharmaceuticals & Biotechnology	208,750	—	2.81%
13	EQ - MAX HEALTHCARE INSTITUTE LTD	Healthcare Services	430,000	—	2.80%
14	EQ - COHANCE LIFESCIENCES LIMITED	Pharmaceuticals & Biotechnology	900,000	—	2.79%
15	EQ - MARKSANS PHARMA LTD.	Pharmaceuticals & Biotechnology	1,000,000	—	2.25%
16	EQ - RAINBOW CHILDRENS MEDICARE LTD	Healthcare Services	240,000	—	2.21%
17	EQ - GLENMARK PHARMACEUTICALS LTD.	Pharmaceuticals & Biotechnology	129,558	—	2.12%
18	EQ- JUPITER LIFE LINE HOSPITALS LTD	Healthcare Services	1,176,815	—	2.09%
19	EQ - AUROBINDO PHARMA LTD.	Pharmaceuticals & Biotechnology	176,850	—	2.07%
20	EQ - FORTIS HEALTHCARE LTD.	Healthcare Services	375,000	—	2.02%
21	EQ - PROCTOR & GAMBLE HEALTH LTD	Pharmaceuticals & Biotechnology	50,000	—	1.95%
22	EQ - ANTHEM BIOSCIENCES LTD	Pharmaceuticals & Biotechnology	300,000	—	1.80%
23	EQ - ASTER DM QUALITY CARE LIMITED	Healthcare Services	360,000	—	1.76%
24	EQ - DR LAL PATHLABS LTD.	Healthcare Services	120,205	—	1.67%
25	EQ - BIOCON LTD.	Pharmaceuticals & Biotechnology	625,000	—	1.62%
26	EQ - METROPOLIS HEALTHCARE LTD	Healthcare Services	386,904	—	1.47%
27	EQ - WINDLAS BIOTEC LTD	Pharmaceuticals & Biotechnology	185,951	—	1.42%
28	EQ - BLUE JET HEALTHCARE LTD	Pharmaceuticals & Biotechnology	375,000	—	1.41%
29	EQ - CIPLA LTD.	Pharmaceuticals & Biotechnology	150,000	—	1.41%
30	EQ - ALEMBIC PHARMACEUTICALS	Pharmaceuticals & Biotechnology	242,802	—	1.40%

UTI - Healthcare Fund

Regular Plan · Growth · where the money sits

A ₹10,000 monthly SIP over five years

Invested	Value	Gain	XIRR
₹600,000	₹1,020,040	₹420,040	21.38%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 28 Oct 2026.